SafeSept RF Transseptal Guidewire - SSRF235
by Pressure Products Medical Device Manufacturing, LLC
510(k) K253799
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK253799 | Date13 Mar 2026 | StatusActive |
| European Union | CE/MDD EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- DXF
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.5175
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The SafeSept RF Transseptal Guidewire is a Catheter, Septostomy, designed for creating a transseptal puncture in cardiac procedures. It combines radiofrequency (RF) technology with a guidewire to facilitate controlled passage through the interatrial septum, aiding in procedures such as atrial septal defect closure or electrophysiology interventions.
This device is supplied sterile and intended for single-use, with models differentiated by size (e.g., SSRF132, SSRF235) and RF-enabled or non-RF variants (indicated by the ‘R’ suffix). It is classified as a Class II medical device under FDA regulations (21 CFR 870.5175) and has received FDA 510(k) clearance as substantially equivalent to a predicate device. Compliance with the Medical Device Directive (MDD) is also noted.
Other devices from Pressure Products Medical Device Manufacturing, LLC
See all devices from Pressure Products Medical Device Manufacturing, LLC →
Questions
AI-generated answers, 18 Sep 2026
What types of cardiac procedures is the SafeSept RF Transseptal Guidewire designed to assist with, and how does it differ from traditional guidewires?
The SafeSept RF Transseptal Guidewire is specifically designed for creating a transseptal puncture during cardiac procedures such as atrial septal defect (ASD) closure or electrophysiology interventions. Unlike traditional guidewires, it combines radiofrequency (RF) technology to facilitate controlled passage through the interatrial septum, reducing the risk of complications during the procedure.
Are there different sizes or variants of the SafeSept RF Transseptal Guidewire, and how do I identify them?
Yes, the SafeSept RF Transseptal Guidewire comes in multiple models differentiated by size (e.g., SSRF132, SSRF235) and whether they include RF technology (indicated by the ‘R’ suffix, such as SSRF132R). For example, SSRF132 and SSRF132R differ only in the presence of RF capability, while SSRF235 and SSRF235R represent a different size variant with or without RF.
Is the SafeSept RF Transseptal Guidewire intended for single-use or can it be reused?
The SafeSept RF Transseptal Guidewire is explicitly supplied sterile and intended for single-use only. Reuse is not recommended or supported, as it could compromise sterility and device performance.
How should the SafeSept RF Transseptal Guidewire be stored, and what precautions should be taken?
The device is supplied sterile, so it should be stored in its original packaging until use to maintain sterility. Store in a clean, dry environment away from direct sunlight or extreme temperatures. Avoid exposure to moisture or contamination, as this could compromise its integrity before use.
What regulatory pathways has the SafeSept RF Transseptal Guidewire followed, and how does this affect its use?
The device has received FDA 510(k) clearance as substantially equivalent to a predicate device under the Medical Device Directive (MDD). It is classified as a Class II medical device (21 CFR 870.5175) and is intended for use in cardiovascular procedures. Compliance with these pathways ensures it meets established safety and performance standards for transseptal guidewires.